Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2023-03-27 00:00:00 ET · period of report 2023-03-24 · accession 0001628280-23-009261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-27 | 2023-03-24 | MYGN | Lambert Nicole | COO | F - Tax | $23.72 | -5,267 | 246.9K | -2% | -$124.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | F | D | 2,143 | $23.72 | 250,063 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-24 | F | D | 3,124 | $23.72 | 246,939 | D | — | — |